课题基金 / 基金详情

Effects of inhalation anesthetics on parasympathetic reflex vasodilatation

Effects of inhalation anesthetics on parasympathetic reflex vasodilatation
吸入麻醉药对副交感神经反射性血管舒张的影响
批准号:
09671886
负责人:
IZUMI Hiroshi
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

IZUMI Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The present experiments were designed to examine the effects of inhalation anesthetics (isoflurane, halothane, and sevoflurane) on the parasympathetic reflex vasodilation in the lower lip and palate elicited by electrical stimulation of the central cut end of the lingual nerve in vago-sympathectomized cats. Isoflurane (1.5%), halothane (1.0 %), sevoflurane (2.5%), each at a concentration of 1.0 MAC (minimum alveolar concentra-tion), markedly suppressed the evoked blood flow increases in the lower lip, whereas nitrous oxide (70 % in 30% oxygen) and morphine (2 mg/kg, iv) did not. Prior administra-tion of picrotoxin, a GABA antagonist, (2 mg/kg, iv) reversed the inhibitory effect of isoflurane on the parasympathetic reflex response. Decerebration had no significant effect on the isoflurane-induced inhibition. These findings suggest that there is a GABA-mediated suppressive mechanism acting on this parasympathetic reflex response ; the sites at which inhalation anesthetics exert such an inhibitory action could be in the mid-brain, pons, or medulla, but not in the hypothalamus or higher structures.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
和泉博之: "自律神経研究における麻酔薬選択の重要性" 循環制御. 18. 341-351 (1997)
Hiroyuki Izumi:“麻醉选择在自主神经研究中的重要性”循环控制 18. 341-351 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ito,Y.,Izumi,H.,et al.: "Suppression of parasympathetic reflex vasodilatation in the lower lip of the cat by isoflurane, propofol, ketamine and pentobarbital : implications for mechanisms underlying the production of anaesthesia" Br.J.Anaesthesia. 81. 563
Ito,Y.,Izumi,H.,et al.:“异氟烷、异丙酚、氯胺酮和戊巴比妥抑制猫下唇的副交感神经反射血管舒张:对麻醉产生机制的影响”Br.J.Anaesthesia
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Izumi, H.: "Review : Nervous control of blood flow in the orofacial region" Pharmac. Therap.,. 81. 141-161 (1999)
Izumi, H.:“评论:口面部区域血流的神经控制”Pharmac。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ito, Y., Izumi, H., Sato, M., Karita, K.and Iwatsuki, N.: "Suppression of parasympathetic reflex vasodilatation in the lower lip of the cat by Isoflurane, propofol, ketamine and pentobarbital : implications for mechanisms underlying the production of anae
Ito, Y.、Izumi, H.、Sato, M.、Karita, K. 和 Iwatsuki, N.:“异氟烷、异丙酚、氯胺酮和戊巴比妥抑制猫下唇副交感神经反射血管舒张:对机制的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    Reconsidering Perspectives and Methodologies of Sound Studies, Studies of Auditory Culture through Max Weber's Music Studies and Methodological Writings
    • 批准号:
      26503002
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.5万
    • 财政年份:
      2014
    • 负责人:
      IZUMI Hiroshi
    • 依托单位:
    Study on analytical techniques of conformations for environmental biopolymers in dynamic equilibrium
    Involvement of sympathoadrenal system in an acute jaw muscle bolld flow increase during sympathoexcitation
    • 批准号:
      21592370
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.25万
    • 财政年份:
      2009
    • 负责人:
      IZUMI Hiroshi
    • 依托单位:
    A Study on Comparisons of Productivity Level and Productivity Growth by industry in Japan, China and South Korea
    • 批准号:
      20530187
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2008
    • 负责人:
      IZUMI Hiroshi
    • 依托单位:
    国内基金
    海外基金
    脑胶质母细胞瘤中SLC1A3⁺小胶质细胞通过Glu-GABA代谢失衡诱导T细胞耗竭的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      崔舒
    • 依托单位:
    基于GABA能神经环路探讨乌藤疏肝丸重塑神经兴奋-抑制平衡的抗抑郁机制
    从肝失疏泄探讨肝脏代谢物介导IL-6/STAT3通路调控GABA能系统对睡眠节律影响的机制及逍遥散的干预作用
    背根神经节GABA重摄取改变在神经痛中的作用及其机制研究
    • 批准号:
      JCZRLH202600149
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: